# Treatment of Erectile Dysfunction - Long Term Safety and Efficacy

> **NCT01065012** · PHASE3 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 1027 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Udenafil 50 mg
- **DRUG:** Udenafil 100 mg
- **DRUG:** Udenafil 150 mg
- **DRUG:** Placebo Matching 50 mg Udenafil
- **DRUG:** Placebo Matching 100 mg Udenafil
- **DRUG:** Placebo Matching 150 mg Udenafil

## Key facts

- **NCT ID:** NCT01065012
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 1027 (ACTUAL)
- **Last updated:** 2015-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01065012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01065012, "Treatment of Erectile Dysfunction - Long Term Safety and Efficacy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01065012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*